Latest News

High adverse events with TB prevention in HIV-infected pregnant women


 

FROM CROI 2018

“I think we now need to reweigh the evidence for pros and cons for IPT in pregnancy,” Dr. Gupta concluded.

The study was sponsored the National Institutes of Health. Dr. Gupta reported having nothing to disclose.

SOURCE: Gupta A et al. CROI 2018, Abstract Number 142LB.

Pages

Recommended Reading

Prenatal ART regimen with lowest risk is TDF-FTC-EFV
MDedge ObGyn
VIDEO: How to prevent, manage perinatal HIV infection
MDedge ObGyn
Herpes simplex type 2 infection markedly increases HIV risk
MDedge ObGyn
HIV antiretroviral resistance can affect more than 10% of pregnant women
MDedge ObGyn
Delayed HIV diagnoses still substantial for some at-risk groups
MDedge ObGyn
Teens with PID underscreened for HIV, syphilis
MDedge ObGyn
HHS creates new religious freedoms division
MDedge ObGyn
Trial seeks improved regimens for pregnant women with HIV
MDedge ObGyn
nPEP for HIV: Updated CDC guidelines available for primary care physicians
MDedge ObGyn
Efavirenz-based ART may hamper vaginal ring contraception
MDedge ObGyn